SCHEMBL174782

SCHEMBL174782

Cc1cc(Nc2nc(CO)nc3cccc(-c4ccc(F)c(F)c4)c23)n[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 8/20 0.47
AURKA O14965 6/20 0.45
AURKB Q96GD4 5/20 0.45
PLK4 O00444 2/20 0.43
NTRK3 Q16288 1/20 0.42
NTRK2 Q16620 1/20 0.42
GSK3B P49841 2/20 0.41
SRC P12931 1/20 0.41
EIF2AK2 P19525 1/20 0.41
GSK3A P49840 1/20 0.41
JAK2 O60674 3/20 0.39
CYP3A4 P08684 3/20 0.39
CYP2C8 P10632 3/20 0.39
CYP2C9 P11712 3/20 0.39
JAK1 P23458 3/20 0.39
TYK2 P29597 3/20 0.39
CYP2C19 P33261 3/20 0.39
JAK3 P52333 3/20 0.39
ADORA3 P0DMS8 2/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL174435 0.91 AURKA (0.50) NTRK1AURKAAURKBPLK4NTRK3
Hydrochloric Acid SCHEMBL174764 0.90 AURKA (0.49) NTRK1AURKAAURKBPLK4NTRK3
SCHEMBL187199 0.80 AURKA (0.52) NTRK1AURKAAURKBGSK3BSRC
SCHEMBL14432758 0.76 NTRK1 (0.47) NTRK1AURKAAURKBPLK4NTRK3
SCHEMBL174676 0.75 PLK4 (0.45) NTRK1AURKAAURKBPLK4GSK3B
SCHEMBL15232334 0.74 AURKA (0.76) NTRK1AURKAAURKBGSK3BSRC
Hydrochloric Acid SCHEMBL28561065 0.74 AURKA (0.74) NTRK1AURKAAURKBGSK3BSRC
SCHEMBL17501774 0.74 AURKA (0.53) NTRK1AURKAAURKBPLK4NTRK3
SCHEMBL174948 0.73 SYK (0.42) NTRK1AURKAAURKBPLK4GSK3B
SCHEMBL187921 0.70 NTRK1 (0.52) NTRK1AURKAAURKBNTRK3NTRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611502-A1 ADENOSINE A3 RECEPTOR MODULATING COMPOUNDS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2013-07-10 EP disclosed
WO-2012030918-A1 ADENOSINE A3 RECEPTOR MODULATING COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2012-03-08 WO disclosed
EP-2401267-A1 JAK KINASE MODULATING QUINAZOLINE DERIVATIVES AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2012-01-04 EP disclosed
WO-2010099379-A1 JAK KINASE MODULATING QUINAZOLINE DERIVATIVES AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2010-09-02 WO disclosed